Updated March 4 at 7:04pm
Biotechnology
43 results total, viewing 1 - 10
How’s this for a job perk: knowing your work helps people suffering from painful, debilitating, chronic illnesses to get out of bed, move without agony and even enjoy life. more
Global biotech firm Covidien PLC has acquired Israeli medical tech company Given Imaging Ltd. for $860 million, a move that will allow Covidien to expand into the multibillion dollar gastrointestinal product market. The acquisition is expected to add between $40 and $50 million in quarterly revenue for Covidien. more
IlluminOss Medical has been issued two patents related to its internal bone fixing system, the company announced Tuesday. more
The Champlin Foundations awarded the University of Rhode Island three grants totaling $421,795 to purchase high-tech equipment to advance education and student learning. more
Nabsys Inc. has named Tony Shuber vice president and chief scientific officer in its latest move toward bringing its genome-mapping products to market. more
Mnemosyne Pharmaceuticals Inc. appointment of Vanessa King as president and CEO. more
Tech Collective, Rhode Island’s bioscience and information technology industry association will host a Bioscience Industry Skills Gap Forum on Wednesday, March 26 from 8:30 to … more
U.S. stocks fell a second day from record levels, with the Nasdaq Composite Index tumbling the most since April, as investors sold Internet and biotechnology shares before the start of earnings season. more
Medtronic Inc., the second-largest maker of medical devices, agreed to buy Covidien PLC for $42.9 billion in cash and stock as it transforms into a broader-based company bolstered by new tax advantages. more
The biosciences comprise a burgeoning industry and important opportunity for Rhode Island. The state’s bioscience industry employs 4,602 bioscience professionals and has a total employment impact of an additional 11,847 workers. On a national and global scale, Rhode Island bioscience companies and professionals participate in the industry’s five primary sectors: drugs and pharmaceuticals; medical devices and equipment; research, testing, and medical laboratories; agricultural feedstock and chemicals; and bioscience-related distribution. more
1 | 2 | 3 | 4 | 5 Next »